Tetra Bio-Pharma Inc.
TBP
Peringkat dalam Saham
#35441
Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical... Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical company focused on discovering and developing cannabinoid-based medications. Their efforts span several therapeutic areas, including inflammation, pain management, ophthalmology, and oncology. The company's pipeline features various drug candidates: PLENITUDE is being developed for cancer-related pain in advanced patients, while REBORN addresses breakthrough cancer pain. Reduvo is designed to combat chemotherapy-induced nausea and vomiting. ARDS-003 targets sepsis and the prevention of acute respiratory distress syndrome, and SERENITY aims to treat cancer cachexia. Furthermore, Tetra Bio-Pharma is advancing PPP003 for painful dry eye and uveitis pain, and HCC011 for hepatocellular carcinoma.
Harga Saham
$0.01851783
Terakhir disinkronkan: 2023-05-23
Kapitalisasi Pasar
$3.71M
Perubahan (1 hari)
-0.04%
Perubahan (1 tahun)
1,443.15%
Negara
CA
Perdagangan Tetra Bio-Pharma Inc. (TBP)
Kategori
Healthcare
EPS untuk Tetra Bio-Pharma Inc. (TBP)
EPS per 2026 TTM: 0
Menurut laporan keuangan terbaru dan harga saham Tetra Bio-Pharma Inc., EPS perusahaan saat ini (TTM) adalah 0. Pada akhir 2026, perusahaan memiliki EPS sebesar 0 sama dengan EPS tahun 2026 sebesar 0.
Riwayat EPS untuk Tetra Bio-Pharma Inc. dari 2026 hingga 2026
EPS di akhir setiap tahun
| Tahun | EPS | Mengubah |
|---|---|---|
| Tidak cukup data untuk tanggal yang disediakan. | ||
EPS untuk perusahaan sejenis atau pesaing
| Perusahaan | EPS | Perbedaan EPS | Negara |
|---|---|---|---|
| $17.32 | - |
US
|
|
| $-7.98 | - |
US
|
|
| $-5.29 | - |
AU
|
|
| - | - |
CH
|
|
| $27.74 | - |
NL
|
